title: Is there a rationale for high-dose chemotherapy as first line treatment of advanced Hodgkin's disease? German Hodgkin's Lymphoma Study Group (GHSG).
authors.affiliation: Klinik I für Innere Medizin, Universität Köln, Germany.
authors.forename: D
authors.initials: D
authors.lastname: Hasenclever
authors.forename: N
authors.initials: N
authors.lastname: Schmitz
authors.forename: V
authors.initials: V
authors.lastname: Diehl
mesh_terms: D006689:Hodgkin Disease / Q000188:drug therapy* / Q000473:pathology; D006801:Humans; D009367:Neoplasm Staging; D012307:Risk Factors